Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation
Not Applicable
- Conditions
- Cerebral Arterial Diseases
- Interventions
- Device: REVIVIEW dichoptic audio-visual stimulation
- Registration Number
- NCT03632564
- Lead Sponsor
- Visior Technologies Ltd.
- Brief Summary
Modulation of brain blood flow using dichoptic Visual and Auditory stimulation using REVIVIEW system will be evaluated.
- Detailed Description
The participant will undergo baseline MRI to measure blood flow in the brain for comparison later on. After baseline MRI, the participant will observe stimulation using the REVIVIEW system for 20 minutes. The content the participants will see is a nature documentary, after which the participant will undergo additional MRI imaging to assess the change in blood flow in the brain.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- healthy subjects
Exclusion Criteria
- History of brain diseases
- Glasses
- Diagnosed with Diabetes
- Diagnosed with Degenerative brain diseases
- Inability to undergo MRI
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Stimulation Arm REVIVIEW dichoptic audio-visual stimulation REVIVIEW dichoptic audio-visual stimulation
- Primary Outcome Measures
Name Time Method Change in blood flow in the brain in respond to the stimulation 1 hour Evaluate the change in blood flow in different parts of the brain, compared with baseline, after the cessation of stimulation, after 30 minutes and after 60 minutes.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sheba Medical Center
🇮🇱Ramat Gan, Israel